Harvard Bioscience, Inc. HBIO

7.96 (0.06) (0.75%) as of 25 Sep
Market cap
$36.5M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
8.61 4.11 4.28 4.51 7.82 8.32 8.34 8.17 5.19 5.60
Receivables
16.04 14.87 16.10 16.71 21.83 17.77 20.70 21.46 17.09 19.92
Inventory
20.81 23.25 24.72 26.44 27.59 22.26 22.06 25.09 16.85 19.96
Other current assets
2.76 2.90 3.94 3.47 4.34 3.36 2.47 3.11 8.40 4.18
Total current assets
48.23 45.12 49.04 51.12 61.58 51.70 53.57 57.83 47.54 45.47
Property, Plant, Equpment (Net)
4.79 5.11 3.98 3.37 3.42 3.96 4.78 5.90 3.74 4.30
Goodwill and Intangible Assets (Total)
17.20 67.46 73.10 77.27 85.07 91.74 95.79 103.07 47.61 56.71
Long Term Assets (Tax, Deferred)
— — — — — — — 0.21 0.18 1.16
Long-term assets (Other)
2.69 2.83 6.47 7.78 5.38 1.09 2.27 1.82 10.28 0.13
Total non-current assets
31.85 81.53 88.33 94.24 100.76 104.55 111.30 110.78 61.82 62.29
Total Assets
80.07 126.64 137.37 145.36 162.34 156.25 164.87 168.61 109.35 107.77
Accounts Payable
3.65 4.79 5.55 6.45 4.91 5.97 5.34 7.36 4.41 6.20
Accrued Expenses
— — — — — — 0.61 0.98 4.21 4.77
Current Part of Debt
— 36.96 5.86 3.81 3.24 1.72 6.90 5.98 2.77 2.37
Current Revenue (Deferred)
— — — 3.37 4.27 3.77 3.95 3.82 0.51 0.50
Other current liabilities
18.31 13.22 15.13 10.86 10.76 7.48 6.70 7.35 2.15 0.76
Total current liabilities
21.96 54.96 26.54 23.25 25.32 21.05 25.31 25.49 14.04 14.60
Long Term Debt (Total)
35.87 — 30.70 43.01 45.10 46.29 46.92 54.81 8.98 11.37
Long Term Tax Liability (Deferred)
0.32 0.71 0.78 0.59 1.56 1.90 1.97 2.30 2.65 6.42
Non-current Liabilities (Other)
1.31 1.26 1.48 1.01 0.49 2.85 0.75 3.29 2.78 3.18
Total non-current liabilities
44.38 8.35 37.75 49.89 53.63 58.52 57.86 60.40 14.41 20.97
Total liabilities
66.34 63.30 64.29 73.14 78.94 79.57 83.18 85.89 28.45 35.57
Additional Paid In Capital
239.67 236.58 232.44 229.01 225.65 232.36 229.19 226.38 218.79 215.13
Common Stock (Net)
0.45 0.44 0.43 0.45 0.45 0.44 0.44 0.44 0.42 0.42
Retained Earnings
(214.71) (158.01) (145.60) (142.19) (132.67) (132.39) (124.58) (119.89) (116.97) (116.03)
Treasury Stock
— — — — — 10.67 10.67 10.67 10.67 10.67
Common Equity (Total)
13.73 63.34 73.07 72.22 83.40 76.68 81.69 82.72 80.90 72.20
Shareholders Equity (Total)
13.73 63.34 73.07 72.22 83.40 76.68 81.69 82.72 80.90 72.20
Shareholders Equity and Liabilities (Total)
80.07 126.64 137.37 145.36 162.34 156.25 164.87 168.61 109.35 107.77
Shares (Common)
4.47 4.41 4.34 4.21 4.11 3.94 3.82 3.74 3.50 3.44
Shareholders Equity (Tangible)
(3.46) (4.12) (0.03) (5.05) (1.67) (15.06) (14.09) (20.34) 33.29 15.48
Net Debt
27.26 32.85 32.28 42.32 40.51 39.69 45.48 52.62 6.56 8.15
Total Debt
35.87 36.96 36.56 46.82 48.33 48.01 53.82 60.80 11.75 13.75

Fold the line items

In millions of $ except per-share values · columns are period end dates